Alisertib in Treating Patients With Recurrent or Persistent Leiomyosarcoma of the Uterus
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Hyman
NRG Oncology
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
50 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Hartford Hospital
Hartford, Connecticut, United States
- Smilow Cancer Hospital Care Center at Saint Francis
Hartford, Connecticut, United States
- the Hospital of Central Connecticut
New Britain, Connecticut, United States
- Florida Hospital Orlando
Orlando, Florida, United States
- University of Hawaii Cancer Center
Honolulu, Hawaii, United States
- Saint Alphonsus Cancer Care Center-Boise
Boise, Idaho, United States
- University of Chicago Comprehensive Cancer Center
Chicago, Illinois, United States
- Sudarshan K Sharma Md Limted-Gynecologic Oncology
Hinsdale, Illinois, United States
- Indiana University/melvin and Bren Simon Cancer Center
Indianapolis, Indiana, United States
- Saint Vincent Hospital and Health Care Center
Indianapolis, Indiana, United States
- Mcfarland Clinic Pc-William R Bliss Cancer Center
Ames, Iowa, United States
- Iowa Lutheran Hospital
Des Moines, Iowa, United States
- Iowa Methodist Medical Center
Des Moines, Iowa, United States
- Iowa-Wide Oncology Research Coalition Ncorp
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Des Moines
Des Moines, Iowa, United States
- Medical Oncology and Hematology Associates-Laurel
Des Moines, Iowa, United States
- Mercy Medical Center - Des Moines
Des Moines, Iowa, United States
- University of Iowa/holden Comprehensive Cancer Center
Iowa City, Iowa, United States
- Michigan Cancer Research Consortium Ncorp
Ann Arbor, Michigan, United States
- Saint Joseph Mercy Hospital
Ann Arbor, Michigan, United States
- Beaumont Hospital-Dearborn
Dearborn, Michigan, United States
- Saint John Hospital and Medical Center
Detroit, Michigan, United States
- Hurley Medical Center
Flint, Michigan, United States
- Genesys Regional Medical Center
Grand Blanc, Michigan, United States
- Allegiance Health
Jackson, Michigan, United States
- Sparrow Hospital
Lansing, Michigan, United States
- Saint Mary Mercy Hospital
Livonia, Michigan, United States
- Saint Joseph Mercy Oakland
Pontiac, Michigan, United States
- Lake Huron Medical Center
Port Huron, Michigan, United States
- Saint Mary'S of Michigan
Saginaw, Michigan, United States
- University of Mississippi Medical Center
Jackson, Mississippi, United States
- Cancer Research for the Ozarks Ncorp
Springfield, Missouri, United States
- Coxhealth South Hospital
Springfield, Missouri, United States
- Mercy Hospital Springfield
Springfield, Missouri, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- Nebraska Methodist Hospital
Omaha, Nebraska, United States
- Memorial Sloan-Kettering Cancer Center
New York, New York, United States
- Unc Lineberger Comprehensive Cancer Center
Chapel Hill, North Carolina, United States
- Carolinas Medical Center/levine Cancer Institute
Charlotte, North Carolina, United States
- Southeast Clinical Oncology Research (scor) Consortium Ncorp
Winston-Salem, North Carolina, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Aug 2012
- Primary completion
- 31 Aug 2014
- Completion
- 11 Feb 2017
- Last update posted
- 23 Jul 2019
- Registered enrollment
- 23
- Registry id
- NCT01637961
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.